Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 821 of 1,261

  1. US 8697138

    Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

    Aker Biomarine AS · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  2. US 8697034

    Hyperpolarized 89-yttrium and methods relating thereto

    The Board of Regents of the University of Texas System · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  3. US 8695119

    Coated elastomeric article and method for making a coated elastomeric article

    Precision Components, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  4. US 8697060

    Treatment method for relapsing-remitting multiple sclerosis

    REGENEX LLC · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  5. US 8697046

    Methods of administering interferon gamma to absorb fluid from the subretinal space

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  6. US 8697076

    Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies

    Northwestern University · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  7. US 8697079

    IgE antibodies for the treatment of cancer

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  8. US 8697082

    Prevention and treatment of synucleinopathic and amyloidogenic disease

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  9. US 8697649

    Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides

    China Medical University · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  10. US 8697375

    In vivo biofilm infection diagnosis and treatment

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  11. US 8697644

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  12. US 8697704

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  13. US 8697744

    Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  14. US 8697865

    Cyclic amide derivative, and its production and use

    Takeda Pharmaceutical Company Limited · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  15. US 8697858

    Antisense antiviral compound and method for treating influenza viral infection

    Sarepta Therapeutics, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  16. US 8697874

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  17. US 8697853

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  18. US 8697848

    Method for reducing immunogenicity of therapeutic protein compositions

    The Regents of the University of Colorado · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  19. US 8697709

    Fused ring heteroaryl kinase inhibitors

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  20. US 8697730

    5-lipoxygenase activating protein (FLAP) inhibitor

    Panmira Pharmaceuticals, LLC · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  21. US 8697724

    Crystalline oxalate salts of a diamide compound

    Theravance, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  22. US 8697727

    N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  23. US 8697698

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  24. US 8697689

    Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.